Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
140
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2

Xia Li1 Respiratory Department of Internal Medicine, Rizhao People’s Hospital of Shandong Province, Rizhao, Shandong, 276800, China
,
Fang Li1 Respiratory Department of Internal Medicine, Rizhao People’s Hospital of Shandong Province, Rizhao, Shandong, 276800, China
,
Fangfang Wang2 Pulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China
,
Jinfeng Li2 Pulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China
,
Cunzhi Lin2 Pulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China
&
Jianxin Du2 Pulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, ChinaCorrespondence[email protected]
Pages 2981-2989 | Published online: 22 May 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohammed Muqtader Ahmed, Farhat Fatima, Md. Khalid Anwer, Mohammed F. Aldawsari, Saurabh Bhatia & Ahmed Al-Harrasi. (2021) Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines. Drug Development and Industrial Pharmacy 47:7, pages 1112-1120.
Read now
Maojian Chen, Wei Jiang, Chanchan Xiao, Weiping Yang, Qinghong Qin, Anyun Mao, Qixing Tan, Bin Lian & Changyuan Wei. (2020) Sodium Butyrate Combined with Docetaxel for the Treatment of Lung Adenocarcinoma A549 Cells by Targeting Gli1. OncoTargets and Therapy 13, pages 8861-8875.
Read now

Articles from other publishers (8)

Shabnam Fakhari, Mina Jamzad, Azita Nouri, Samira Arab-Salmanabadi & Foujan Falaki. (2022) A novel polyamidoamine dendrimer based nano-carrier for oral delivery of imatinib. Journal of Polymer Research 29:12.
Crossref
Xinmin Meng, Xue Zhu, Jiali Ji, Hongqin Zhong, Xiyue Li, Hongqing Zhao, Guijuan Xie, Ke Wang, Hong Shu & Xun Wang. (2022) Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor. Molecules 27:19, pages 6733.
Crossref
Shaohui Wang, Nan Xing, Xianli Meng, Li Xiang & Yi Zhang. (2022) Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma. Frontiers in Pharmacology 13.
Crossref
Anna Bryl, Mariusz Falkowski, Katarzyna Zorena & Małgorzata Mrugacz. (2022) The Role of Resveratrol in Eye Diseases—A Review of the Literature. Nutrients 14:14, pages 2974.
Crossref
Kusum Devi, Sakshi Soni, Vineeta Tripathi, Richa Pandey & Baisakhi Moharana. (2022) Ethanolic Extract of Tridax procumbens Mitigates Pulmonary Inflammation via Inhibition of NF-κB/p65/ERK Mediated Signalling in an Allergic Asthma Model. Phytomedicine 99, pages 154008.
Crossref
Chandra K. Maharjan, Jiao Mo, Lei Wang, Myung-Chul Kim, Sameul Wang, Nicholas Borcherding, Praveen Vikas & Weizhou Zhang. (2021) Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer. Cancers 14:1, pages 206.
Crossref
Tiantian Meng, Dingfu Xiao, Arowolo Muhammed, Juying Deng, Liang Chen & Jianhua He. (2021) Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules 26:1, pages 229.
Crossref
Kai Liu, Yingang Zhang, Liang Liu & Qiling Yuan. (2019) miR-125 regulates PI3K/Akt/mTOR signaling pathway in rheumatoid arthritis rats via PARP2. Bioscience Reports 39:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.